A new study calls attention to the need for better partnerships between primary care physicians and oncologists.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Comprehensive Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined the University of Michigan Health System in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
A new national initiative will change the face of clinical trials for pancreatic cancer through collaboration among researchers, clinicians and pharma.
Understanding who has the highest risk of rare cancers, including squamous cell esophageal cancer, suggests a potential for targeted screening recommendations.
The tiny, scaffoldlike device facilitates early detection of metastatic cancer cells and improves survival, a new study finds.
A metabolic cross-talk pathway between cancer and noncancer cells in pancreatic tumors delivers an alternative nutrient to the cancer cells, facilitating tumor growth.
Few tumor samples from minorities means research is likely missing key mutations that fuel cancer in different racial or ethnic groups.